Revenue Guidance -- Management reiterated full-year fiscal 2025 revenue guidance of $26 million to $30 million and set Q4 ...

When 28- year-old Sofia booked a derm appointment for a mole that had "decided to grow its own personality," she expected two things: a quick removal and her insurance to pick up the tab. After all, ...

SPOKANE VALLEY, Wash., Nov. 04, 2025 (GLOBE NEWSWIRE) -- KeyTronic Corporation (Nasdaq: KTCC), a provider of electronic manufacturing services (EMS), today announced its results for the quarter ended ...

AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions ('AVITA Medical,” or the 'Company”), today reported financial results ...

Q3 2025 Earnings Call November 6, 2025 8:30 AM ESTCompany ParticipantsEric Burns - Vice President of Finance & ...

2025 Financial Guidance Sight Sciences raises its revenue guidance expectations for full year 2025 to $76.0 million to $78.0 million, representing a 2% to 5% decline compared to full year 2024 revenue ...

Q3 2025 Earnings Call Transcript November 11, 2025 Operator: Good morning, everyone, and welcome to the Xtant Medical ...

Q3 2025 Earnings Call Transcript November 13, 2025 Bionano Genomics, Inc. beats earnings expectations. Reported EPS is ...

Bionano Genomics, Inc. ( BNGO) Q3 2025 Earnings Call November 13, 2025 4:30 PM EST Good day, and welcome to the Bionano Third Quarter 2025 Earnings Conference Call. Today's conference is being ...

I. INTRODUCTION - Brand license agreements can drive business growth and brand recognition. By granting rights to use, develop, ...

CHANGE OF INVESTMENT OBJECTIVE At the annual meeting on 5th December, shareholders approved the proposal by your Board to change the investment objective from long-term capital growth to long-term ...

The China-ASEAN FTA 3.0 strengthens both "hard connectivity" -- such as cross-border fiber optics and data centers, and "soft ...